ISRG Stock: The Math Hidden In Its Price

Intuitive Surgical (ISRG) trades at $353 with a 42.1x P/E multiple, implying the market expects 14.1% annual revenue growth over the next 4 years. That is well below the current 21% growth rate, suggesting the stock has already priced in a slowdown that has not yet materialized.

Rating Change

No specific analyst rating change is mentioned, but the analysis implies that the current valuation reflects lower growth expectations than actual performance.

Analyst's Rationale

The article presents a simple mathematical analysis: the current stock price ($353) and P/E multiple (42.1x) imply the market expects 14.1% annual revenue growth for 4 years. This is significantly lower than the current growth rate of 21%, meaning the market has already priced in a future slowdown that has not yet appeared in the data.

Context

Intuitive Surgical is a leader in robotic surgery, enjoying strong revenue growth due to increasing adoption of its systems. However, the high valuation (42.1x) makes the stock vulnerable to any growth deceleration.

What We Conclude

The analysis does not recommend buying or selling, but highlights that the current valuation may not be as stretched as it appears, because the market is already expecting a slowdown. If current growth persists, the stock could be undervalued.